NENCINI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.638
EU - Europa 1.823
AS - Asia 1.411
SA - Sud America 149
AF - Africa 35
OC - Oceania 22
Totale 6.078
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.605
RU - Federazione Russa 615
SG - Singapore 446
PL - Polonia 443
CN - Cina 365
IT - Italia 226
HK - Hong Kong 164
VN - Vietnam 132
BR - Brasile 120
IE - Irlanda 108
SE - Svezia 103
KR - Corea 96
FI - Finlandia 68
DE - Germania 64
FR - Francia 60
GB - Regno Unito 56
IN - India 53
JO - Giordania 38
BD - Bangladesh 30
AU - Australia 22
CA - Canada 20
JP - Giappone 19
ID - Indonesia 16
TR - Turchia 16
NL - Olanda 15
AR - Argentina 14
BE - Belgio 13
ES - Italia 9
UA - Ucraina 9
CH - Svizzera 8
NG - Nigeria 8
CI - Costa d'Avorio 7
MX - Messico 7
MA - Marocco 6
CO - Colombia 5
CZ - Repubblica Ceca 5
GR - Grecia 5
IQ - Iraq 5
PK - Pakistan 5
ZA - Sudafrica 5
EC - Ecuador 4
LT - Lituania 4
SA - Arabia Saudita 4
AT - Austria 3
KZ - Kazakistan 3
LV - Lettonia 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BJ - Benin 2
DZ - Algeria 2
EE - Estonia 2
GE - Georgia 2
JM - Giamaica 2
NP - Nepal 2
PH - Filippine 2
TN - Tunisia 2
UY - Uruguay 2
AM - Armenia 1
BH - Bahrain 1
BY - Bielorussia 1
CL - Cile 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
HN - Honduras 1
HU - Ungheria 1
KE - Kenya 1
MM - Myanmar 1
NI - Nicaragua 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TM - Turkmenistan 1
TW - Taiwan 1
VE - Venezuela 1
Totale 6.078
Salva come PNG Salva come JPEG
Città #
Santa Clara 452
Warsaw 442
Ashburn 408
Singapore 314
Fairfield 175
Hong Kong 138
Chandler 136
San Jose 131
Dublin 109
Seoul 96
Beijing 95
Cambridge 84
Woodbridge 84
Ann Arbor 73
Houston 72
Seattle 70
Dallas 64
Wilmington 64
Hefei 57
Buffalo 47
The Dalles 45
Ho Chi Minh City 42
Los Angeles 40
Munich 39
New York 38
Lawrence 37
Altamura 35
Florence 35
Lauterbourg 34
Council Bluffs 32
Princeton 29
Hanoi 27
Moscow 25
Mumbai 23
Shanghai 22
Helsinki 21
Jacksonville 19
Medford 19
Melbourne 19
Tokyo 19
Kent 18
Milan 18
Boardman 16
Paris 15
Turku 15
Boston 14
London 13
Brussels 12
Jakarta 12
Lappeenranta 12
Frankfurt am Main 11
São Paulo 10
Chicago 9
Izmir 9
Luni 9
Abuja 8
Norwalk 8
Abidjan 7
Phoenix 7
Toronto 7
Dong Ket 6
Redondo Beach 6
San Francisco 6
Andover 5
Bengaluru 5
Livorno 5
New Delhi 5
Orem 5
Ottawa 5
Rome 5
Washington 5
Amman 4
Amsterdam 4
Atlanta 4
Charlotte 4
Clifton 4
Falls Church 4
Haiphong 4
Hải Dương 4
Ioannina 4
Johannesburg 4
Ninh Bình 4
Salvador 4
Ankara 3
Baghdad 3
Barcelona 3
Buenos Aires 3
Chennai 3
Da Nang 3
Dhaka 3
Fortaleza 3
Guangzhou 3
Guayaquil 3
Madrid 3
Montreal 3
Olomouc 3
Palermo 3
Ponti sul Mincio 3
Riga 3
Rio de Janeiro 3
Totale 4.098
Salva come PNG Salva come JPEG
Nome #
A novel allergen-adjuvant conjugate suitable for specific immunotherapy of respiratory allergy 376
Treatment with 8-OH-modified adenine (TLR7 ligand)-allergen conjugates decreases T helper type 2-oriented murine airway inflammation 359
Dermatophagoides pteronyssinus group 2 allergen bound to 8-OH modified adenine reduces the Th2-mediated airway inflammation without inducing a Th17 response and autoimmunity 292
Efficacy and safety of mepolizumab (Anti-Interleukin-5) treatment in Gleich's syndrome 231
High proportion of inflammatory CD62Llow eosinophils in blood and nasal polyps of severe asthma patients 217
The TLR7 Ligand 9-Benzyl-2-Butoxy-8-Hydroxy Adenine Inhibits IL-17 Response by Eliciting IL-10 and IL-10-Inducing Cytokines. 198
Assays and strategies for immunogenicity assessment of biological agents. 194
Skin testing and infliximab-specific antibodies detection as a combined strategy for preventing infusion reaction. 192
A novel nDer p2-conjugated TLR7 down-modulates Th2-associated lung inflammation by using a therapeutical protocol 182
Anti-infliximab IgE and non-IgE antibodies and induction of infusion-related severe anaphylactic reactions. 180
Drug-Specific Th2 Cells and IgE Antibodies in a Patient with Anaphylaxis to Rituximab 179
The percentage of patients achieving complete remission of urticaria increases with repeated courses of treatment 177
The anti-IgE monoclonal antibody omalizumab as adjuvant treatment in desensitization to carboplatin in patients with ovarian cancer 168
Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary Study 164
Manifestations of Antidrug Antibodies Response: Hypersensitivity and Infusion Reactions. 161
Low-dose mepolizumab effectiveness in patients suffering from eosinophilic granulomatosis with polyangiitis 157
A modified adenine chemically coupled to allergen molecole redirects allergen-specific Th2 cells 153
Modified adenine (9-benzyl-2-butoxy-8-hydroxyadenine) redirects Th2-mediated murine lung inflammation by triggering TLR7. 149
A novel antigen-conjugated TLR7 ligand regulates the lung inflammation and Th2-mediated response in a murine model of asthma 145
Comparison of ELISA with automated ECLIA for IL-6 determination in COVID-19 patients: An Italian real-life experience 143
Long-term retention rate of mepolizumab treatment in severe asthma: a 36-months real-life experience 143
Etanercept inhibits the TNF-α driven shifting of Th17 towards non-classic Th1 phenotype in juvenile idiopathic arthritis. 141
Drug-specific Treg cells are induced during desensitization procedure for rituximab and tocilizumab in patients with anaphylaxis 139
Modified adenine (9-benzyl-2-butoxy-8-hydroxyadenine) redirects Th2-mediated murine lung inflammation by triggering TLR7. 135
Allergological in vitro and in vivo evaluation of patients with hypersensitivity reactions to infliximab. 132
Circulating T cells to infliximab are detectable mainly in treated patients developing anti-drug antibodies and hypersensitivity reactions 130
Post-translational modifications of fibrinogen: implications for clotting, fibrin structure and degradation 129
Hydroxy-adenines as in vivo and in vitro immunomodulators of allergic responses 125
The Kinetics of Antidrug Antibodies, Drug Levels, and Clinical Outcomes in Infliximab-Exposed Patients with Immune-Mediated Disorders 122
Short and long-term effect of a novel nDer p2-conjugated TLR7 ligand in the prevention of allergic lung inflammation 119
Fibrinogen Structural Changes and Their Potential Role in Endometriosis-Related Thrombosis 112
Immunogenicity of Biological Agents: Basic Knowledge and Clinical Implications 110
Dietary Antioxidants and Natural Compounds in Preventing Thrombosis and Cardiovascular Disease 102
Modified (2-Butoxy-8-Hydroxy-9-Benzyl) adenine redirects type 2 murine lung inflammation by triggering TLR7 in dendritic cells 88
Fibrinogen glycosylation and glycation: molecular insights into thrombosis and vascular disease 67
Fibrinogen Oxidation and Thrombosis: Shaping Structure and Function 62
The Erythrocyte–ROS Axis in Thrombosis and Hemostasis 53
Homocysteinylation of Fibrinogen: A Post-Translational Link to Thrombosis 51
ROS‐induced modifications of fibrin clots connect immune responses to atherothrombosis in systemic lupus erythematosus 47
Complete blood count in neonatal Intensive care Unit (NICU): Performance comparison between POCT Sight OLO® and Sysmex XN-9100™ hematology analyzers 40
Reactive Nitrogen Species and Fibrinogen: Exploring the Effects of Nitration on Blood Clots 34
null 14
Reactive Oxygen Species–Induced Modifications of Fibrin Clots as a Link Between Immune Responses and Atherothrombosis in Systemic Lupus Erythematosus 4
Totale 6.116
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.447
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.447
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202135 0 0 0 0 0 0 0 0 0 0 20 15
2021/2022200 4 16 16 5 8 11 7 19 7 11 45 51
2022/2023589 48 124 29 34 40 95 73 36 81 5 13 11
2023/2024291 15 23 32 24 34 38 21 58 6 11 10 19
2024/20251.624 64 169 102 262 416 181 40 82 92 56 81 79
2025/20262.166 252 269 227 183 265 95 303 119 158 154 141 0
Totale 6.116